A series of iron oxide supported on alumina-intercalated clay catalysts (named Fe/Al-Lap catalysts) with mesoporous structure and high specific surface area were prepared. The structural and chemical properties were studied by nitrogen sorption isotherms, X-ray diffraction (XRD), UV-vis diffuse reflectance spectra (UV-vis DRS), X-ray photoelectron spectra (XPS), Fourier transform infrared spectroscopy (FTIR), H₂ temperature-programmed reduction (H₂-TPR) and NH₃ temperature-programmed desorption (NH3-TPD) techniques. It was realized that iron oxide mainly existed in the form of isolated Fe(3+) in an oxidic environment. Fe/Al-Lap catalysts showed high catalytic activities in the temperature range of 120-200 °C without the presence of excessive O₂. This can be attributed to the interaction between iron oxide and alumina, which improve the redox property of Fe(3+) efficiently. In addition, the strong acidity of catalysts and good dispersion of iron oxide were also beneficial to oxidation reaction. Among them, 7% Fe/Al-Lap catalyst presented the best catalytic performance at 180 °C. Finally, the catalytic and deactivation mechanisms were explored.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhazmat.2013.05.008DOI Listing

Publication Analysis

Top Keywords

iron oxide
20
oxide supported
8
supported alumina-intercalated
8
clay catalysts
8
fe/al-lap catalysts
8
iron
5
oxide
5
catalysts
5
selective catalytic
4
catalytic oxidation
4

Similar Publications

Biomarkers.

Alzheimers Dement

December 2024

5M Biomed, LLC, Atlanta, GA, USA.

Background: Enriching and detecting Alzheimer's disease (AD) biomarkers in cerebral spinal fluid (CSF) or blood samples are increasingly applied in the AD diagnosis and monitoring of disease progression and treatment response. The accuracy of these processes is dependent on the sensitivity and specificity of capturing and quantifying AD biomarkers, e.g.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

5M Biomed, LLC, Atlanta, GA, USA.

Background: Liquid biopsy for Alzheimer's disease (AD) biomarkers in cerebral spinal fluid (CSF) or blood samples is becoming a significant sector in the management of AD and AD related dementia (ADRD). Whereas different types of molecules, such as small molecules, peptides, and antibodies, have been used as ligands for targeting AD biomarkers/pathologies such as amyloid beta peptides (Aβs), current liquid biopsy approaches mostly use antibodies. However, the activity and affinity of the antibodies can vary depending on the source and preparation as well as the stability in storage.

View Article and Find Full Text PDF

Developing Topics.

Alzheimers Dement

December 2024

Daegu Catholic University, Daegu, Daegu Metropolitan City, Korea, Republic of (South).

Background: The interplaying neuropathology of amyloid plaque, tau tangles, and microglia-driven inflammation (tri-pathology) are related to neuronal and synaptic loss damage in Alzheimer's damages. Interventions that target Aβ or tau individually have not yielded substantial breakthroughs. Iron plays a pivotal role in tri-pathology by protein-bound iron-oxide deposition in amyloid plaque, tau tangle, and microglia, resulting in redox-active toxicity or microglial response induction, such as proinflammatory activation, autophagy dysfunction, and ferroptosis.

View Article and Find Full Text PDF

Background: The metal oxide nanoparticles possess unique properties such as biological compatibility, superior reactivity, and capacity to develop reactive oxygen species, due to this they have drawn significant interest in cancer treatment. The various MONPs such as cerium oxide, Copper oxide, Iron oxide, Titanium dioxide, and Zinc oxide have been investigated for several types of cancers including brain, breast, cervical, colon, leukemia, liver, lung, melanoma, ovarian, and prostate cancers. However, traditional physiochemical synthetic methods for MONPs commonly include toxic materials, a major concern that raises questions regarding their biocompatibility and safety.

View Article and Find Full Text PDF

Introduction: Iron oxide nanozyme was synthesized from the fruit peel extract of pomegranate, which served as a reducing agent during the green synthesis. The scavenging of reactive oxygen species is often accompanied by immunomodulation following antiproliferative effects due to the crosstalk between the proteins involved in the inter-related signaling pathways.

Method: In the current study, the green synthesized nanozyme was studied for its ability to induce apoptosis in breast cancer cell lines.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!